help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 54, No. 1 180-181
doi:10.1210/jcem-54-1-180
Copyright © 1982 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NABIL, N.
Right arrow Articles by AMATRUDAf, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NABIL, N.
Right arrow Articles by AMATRUDAf, J. M.

Methimazole: An Alternative Route of Administration*

NARMEEN NABIL, DAVID J. MINER and JOHN M. AMATRUDAf{dagger}

Endocrine-Metabolism Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry Rochester, New York 14642 Lilly Research Laboratories, Division of Eli Lilly and Company Indianapolis, Indiana 46285

Address all correspondence and requests for reprints to: John M.Amatruda, M.D., Department of Medicine, Endocrine-Metabolism Unit, University of Rochester, Rochester, New York 14642.

Methimazole was administered orally and rectally in a single dose of 60 mg to six euthyroid volunteers (three females and three males). Blood levels of methimazole were the same whether administered by the oral or rectal route, with peak levels of 1184 ± 118 and 1163 ± 150 (±SEM) ng/ml respectively.

This study provides evidence that the rectal administration of methimazole may be an alternative to treating hyperthyroid patients who are unable to take this drug by mouth.

* This work was supported in part by Grant RR-00044 from the Division of Research Resources, NIH.

{dagger} Recipient of NIH Research Career Development Award AM-00366.

Received April 23, 1981.




This article has been cited by other articles:


Home page
NEJMHome page
D. S. Cooper
Antithyroid Drugs
N. Engl. J. Med., March 3, 2005; 352(9): 905 - 917.
[Full Text] [PDF]


Home page
J Intensive Care MedHome page
N. Stathatos and L. Wartofsky
Thyrotoxic Storm
J Intensive Care Med, January 1, 2002; 17(1): 1 - 7.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1982 by The Endocrine Society